App-based symptom tracker aims to boost quality of life for liver cancer patients

NCT ID NCT06938945

Recruiting now Symptom relief Sponsor: Wei Xiaoping Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app that tracks symptoms can improve quality of life for 500 liver cancer patients receiving immunotherapy. Patients in the intervention group report symptoms weekly via the app, which gives personalized advice and alerts doctors if scores are concerning. The control group receives usual care. The goal is to see if digital monitoring helps patients manage side effects and feel better overall.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital symptom monitoring app (behavioral intervention)
What this could lead to: If successful, this could show that a simple app helps liver cancer patients manage symptoms better and improves their quality of life during treatment.
What could go wrong: This is a behavioral intervention, not a drug, so it won't treat the cancer itself. The benefit depends on patients and doctors acting on the alerts, which may not always happen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA (HCC)

Contacts and locations

Locations

China Center for Health Development Studies, Peking University
RECRUITING

Haidian, Beijing Municipality, 100191, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.